Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmace...
Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to redu...
Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics a...
Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first ...
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...
Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent st...
A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, hav...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...
R-Tech Ueno Ltd, headquartered in Tokyo, has acquired the right to develop and commercialize DE-105 from Santen Pharmace...
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...
Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexava...
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...
Tokyo: Daiichi Sankyo Company, Limited has obtained approval for partial changes concerning a supplementary indication ...
